Maxim downgraded Agile Therapeutics to Hold from Buy.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AGRX:
- Agile Therapeutics completes payoff of debt
- Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
- Agile Therapeutics Secures Funding Through Warrant Transactions
- Agile Therapeutics announces exercise of warrants for $4.8M gross proceeds
- Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds